Clinical Trial Update: A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment [NA]

View source ↗

Summary

A clinical trial investigating a CpG-methylation-based assay to stratify stage III clear cell renal cell carcinoma patients for adjuvant treatment; currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Renal Neoplasms, Targeted Molecular Therapy | NA | Status: NOT_YET_RECRUITING